Dr. Reddy's Recalls Paricalcitol Capsules Due to Breakage and Leakage
Dr. Reddy's Laboratories is recalling Paricalcitol capsules due to reports of breakage and leakage. The recall covers 4,383 bottles distributed nationwide.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this recall as Class III, which by definition indicates that use of or exposure to the product is not likely to cause adverse health consequences. The issue is physical breakage and leakage rather than a chemical or biological hazard.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Paricalcitol Capsules, 2 mcg, 30 capsules per bottle. The recall was initiated due to reports of breakage and leakage of the capsules.
The affected product is a prescription-only medication manufactured by Dr. Reddy's Laboratories Limited in Bachupally, India. The recall involves 4,383 bottles distributed nationwide. Specific lot numbers include C404653, C404654, C404655 (Exp 05/2016) and C505010 (Exp 06/2017).
Consumers should stop using the affected product and contact their healthcare provider or pharmacist for guidance. The FDA has classified this recall as Class III, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- PARICALCITOL (PARICALCITOL)
- Brand
- PARICALCITOL
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 4,383
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #s: C404653
- C404654
- C404655
- Exp 05/2016
- C505010
- Exp 06/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · PARICALCITOL
- LowDr. Reddy's Recalls Paricalcitol Capsules Due to Breakage and Leakage
FDA (Drugs) · 2016-02-24
- LowDr. Reddy's Recalls Paricalcitol Capsules Due to Breakage and Leakage
FDA (Drugs) · 2016-02-24
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12